Alerts will be sent to your verified email
Verify Email
DLCL
|
Dr Lalchandani Labs
|
DhanvantriJeevan Rek
|
Global Longlife Hosp
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
6.03 % | 2.68 % | 7.92 % |
|
5yr average Equity Multiplier
|
1.69 | 1.51 | 1.57 |
|
5yr Average Asset Turnover Ratio
|
0.43 | 1.22 | 0.54 |
|
5yr Avg Net Profit Margin
|
1.96 % | -1.83 % | 8.63 % |
|
Price to Book
|
0.0 | 1.09 | 0.0 |
|
P/E
|
30.66 | 91.87 | 74.77 |
|
5yr Avg Cash Conversion Cycle
|
103.23 Days | 30.84 Days | -351.43 Days |
|
Inventory Days
|
78.71 Days | 2.65 Days | 11.26 Days |
|
Days Receivable
|
408.23 Days | 28.6 Days | 716.69 Days |
|
Days Payable
|
262.63 Days | -1976.44 Days | 489.79 Days |
|
5yr Average Interest Coverage Ratio
|
3.16 | 7.8 | 2.59 |
|
5yr Avg ROCE
|
5.08 % | -0.53 % | 12.16 % |
|
5yr Avg Operating Profit Margin
|
14.13 % | 2.35 % | -132.06 % |
|
5 yr average Debt to Equity
|
0.48 | 0.0 | 0.48 |
|
5yr CAGR Net Profit
|
-16.1 % | n/a | -37.22 % |
|
5yr Average Return on Assets
|
1.95 % | -0.6 % | 3.07 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
32.9 % | 19.65 % | 35.44 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-27.88 % | -0.12 % | -18.85 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Dr Lalchandani Labs
|
DhanvantriJeevan Rek
|
Global Longlife Hosp
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|